HOW TO LOSE WEIGHT LIKE A MOVIE STAR
Hollywood industry moguls, reality starlets, veteran film producers, and actors quietly sing this new drug’s praises. Hair, makeup, and styling teams for celebrities have come to accept the injections of this new wonder drug as part of grooming rituals ahead of major events. In a matter of months, it has become the worst-kept secret in Hollywood. So, what is this secret new drug Hollywood is trying to keep under wraps? Introducing tirzepatide, otherwise known by its brand name…Mounjaro!
SO WHAT IS IT…DRUMROLL PLEASE
Mounjaro; it’s the first and only dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) for treating adults with type 2 diabetes and obesity. Mounjaro, whose active ingredient is tirzepatide, is the most potent FDA-approved weight loss medication ever produced, with an average weight loss of more than 23% of starting weight.
IN CASE YOU THINK WE GOT THE NUMBER WRONG
People on Mounjaro have been shown in study after study to experience an average weight loss of more than 23% of starting weight. Those are impressive stats, given that people taking many existing FDA-approved medications for obesity, on average, lose between 5 and 10% of their total body weight.
HERE’S WHERE IT ALL STARTED
Tirzepatide, known as a “twincretin”, was approved as Mounjaro (tirzepatide) by the FDA on May 13, 2022, to treat obesity and type 2 diabetes, often referred to as the twin epidemics of the 21st century.
Obesity is defined by the World Health Organization (WHO) as an “abnormal or excessive fat accumulation that may impair health, leading to an increased risk of serious conditions and diseases such as diabetes, hypertension, cardiovascular disease, cancer, asthma.” To date, the fight against obesity has been one of the greatest challenges.
Type 2 diabetes (T2D) is an incurable condition that influences glucose regulation in the body. A whopping 537 million adults across the globe were suffering from T2D in the year 2021, and this number is estimated to rise to 783 million by the year 2045 (with a surge of 12.2%). Mounjaro is the first new medication for T2D in nearly a decade.
WELL GUESS WHAT?
You don’t have to have T2D or be obese for Mounjaro to help you lose an average of more than 23% of your starting weight. Yes, 23%. It is being used off-label to help people like you lose the weight weighing heavily on your whole life.
GIVE THOSE EXCESS POUNDS THE ONE-TWO PUNCH
Let’s get back to that “dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist)” part.
So we have a class of medication that has been on the market now for about 15 years called GLP-1 receptor agonist, the latest of which had been semaglutide or Ozempic. GLP-1 receptor agonists are powerful incretin hormones that seem to aid in weight loss in two key ways. First, they make the stomach empty more slowly, so you feel satisfied with less food. This helps reduce caloric intake without starving yourself. Second, the GLP-1 receptor agonists reduce appetite, telling your brain when you’re full, and decrease cravings. This allows you to make nutritional choices that better align with your goals. The biological changes from GLP-1 medications may also help reduce your set point weight—the weight your body strives to maintain due to hormones, biology, and surroundings.
GIP is an incretin hormone that enhances the effects of GLP-1 receptor agonists. In studies, GIP added to GLP-1 has been shown to further decrease food intake and increase energy expenditure, therefore, resulting in even greater weight reductions. Together, GLP-1 receptor agonists and GIP work as one. One powerful weight loss solution.
WAIT, INCRETIN HORMONES? THAT’S A NEW ONE
Incretin hormones are metabolic hormones released whenever food is consumed. Among other things, they help promote a feeling of fullness by delaying gastric emptying and activating the satiety centers in the brain. You feel full more quickly and for a longer period of time. GIP and GLP-1 hormones mimic the incretin hormones your body naturally produces when you eat food. The issue with the natural hormones in our body is that they get broken down very quickly. Because Mounjarobinds to these two different incretin hormones, it leads to a much- heightened sensation of fullness and to a much more significant response lasting much longer than what your own body would produce.
THIS IS THE YEAR YOU ARE GOING TO LOOK LIKE A MOVIE STAR
Mounjaro hasn’t just ushered in a new era of dual-targeted treatment for diabetes and obesity; it has ushered in new hope for those of you whose weight loss efforts have too often failed. At Thrive Health Solutions, our experts are excited about adding Mounjaro (tirzepatide) to our broad toolkit of weight loss options. With Mounjaro, you don’t have to take medication every day. Just a small injection once a week will give you results beyond your expectations. The weight loss professionals at Thrive are here to provide the best care possible to every patient. Our main goal is to help you to lose weight in order to improve your overall health. Which is one of the best ways we can help you improve your overall quality of life. Let us help you get there. Text Thrive Health Solutions for an appointment now.
